Circulating biomarker results from a phase 2 study of seralutinib in pulmonary arterial hypertension

Robin Osterhout, Athénaïs Boucly, Raymond L Benza, Richard N Channick, Kelly M Chin, Robert P Frantz, Anna R Hemnes, Luke S Howard, Vallerie V McLaughlin, Olivier Sitbon, Jean-Luc Vachiéry, Roham T Zamanian, Richard Aranda, Matt Cravets, Zhaoqing Ding, Thao Duong-Verlé, David Mottola, Robert F Roscigno, Ravikumar Sitapara, Lawrence S Zisman, Jean-Marie Bruey, Hossein-Ardeschir Ghofrani

Open source

DOI: 10.1093/ajrccm/aamag175
Published: 2026-05-08
Container: American Journal of Respiratory and Critical Care Medicine
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ajrccm/aamag175,
  title = {Circulating biomarker results from a phase 2 study of seralutinib in pulmonary arterial hypertension},
  author = {Robin Osterhout and Athénaïs Boucly and Raymond L Benza and Richard N Channick and Kelly M Chin and Robert P Frantz and Anna R Hemnes and Luke S Howard and Vallerie V McLaughlin and Olivier Sitbon and Jean-Luc Vachiéry and Roham T Zamanian and Richard Aranda and Matt Cravets and Zhaoqing Ding and Thao Duong-Verlé and David Mottola and Robert F Roscigno and Ravikumar Sitapara and Lawrence S Zisman and Jean-Marie Bruey and Hossein-Ardeschir Ghofrani},
  year = {2026},
  journal = {American Journal of Respiratory and Critical Care Medicine},
  doi = {10.1093/ajrccm/aamag175},
  url = {https://doi.org/10.1093/ajrccm/aamag175}
}

RIS

TY  - JOUR
TI  - Circulating biomarker results from a phase 2 study of seralutinib in pulmonary arterial hypertension
AU  - Robin Osterhout
AU  - Athénaïs Boucly
AU  - Raymond L Benza
AU  - Richard N Channick
AU  - Kelly M Chin
AU  - Robert P Frantz
AU  - Anna R Hemnes
AU  - Luke S Howard
AU  - Vallerie V McLaughlin
AU  - Olivier Sitbon
AU  - Jean-Luc Vachiéry
AU  - Roham T Zamanian
AU  - Richard Aranda
AU  - Matt Cravets
AU  - Zhaoqing Ding
AU  - Thao Duong-Verlé
AU  - David Mottola
AU  - Robert F Roscigno
AU  - Ravikumar Sitapara
AU  - Lawrence S Zisman
AU  - Jean-Marie Bruey
AU  - Hossein-Ardeschir Ghofrani
PY  - 2026
JO  - American Journal of Respiratory and Critical Care Medicine
DO  - 10.1093/ajrccm/aamag175
UR  - https://doi.org/10.1093/ajrccm/aamag175
ER  -

APA

Osterhout, R., Boucly, A., Benza, R. L., Channick, R. N., Chin, K. M., Frantz, R. P., Hemnes, A. R., Howard, L. S., McLaughlin, V. V., Sitbon, O., Vachiéry, J., Zamanian, R. T., Aranda, R., Cravets, M., Ding, Z., Duong-Verlé, T., Mottola, D., Roscigno, R. F., Sitapara, R., Zisman, L. S., Bruey, J., & Ghofrani, H. (2026). Circulating biomarker results from a phase 2 study of seralutinib in pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1093/ajrccm/aamag175

Source records

crossref · retrieved 2026-09-26T19:39:29.534Z